Menu

阿托伐他汀进医保了吗?

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

Atorvastatin is indicated for hypercholesterolemia. Patients with primary hypercholesterolemia, including those with familial hypercholesterolemia or mixed hyperlipidemia, can be used if dietary treatment or other non-drug treatments are not effective.

Atorvastatin can also be used for patients with coronary heart disease or coronary heart disease-related risks (such as diabetes, symptomatic atherosclerotic disease, etc.) combined with high cholesterol or mixed dyslipidemia. It is suitable for: reducing the risk of non-fatal myocardial infarction, reducing the risk of fatal and non-fatal stroke, reducing the risk of revascularization, and reducing the risk of hospitalization due to congestive heart failure.

Patients should follow a standard low-cholesterol diet before starting atorvastatin treatment and maintain a reasonable diet throughout the treatment period. Dosage adjustments should be individualized based on baseline LDL cholesterol levels, treatment goals, and patient response.

The usual starting dose of atorvastatin is 10 mg once daily, with dose adjustment intervals of 4 weeks or more, and the maximum atorvastatin dose is 80 mg once daily. The daily dose of atorvastatin can be taken in one dose at any time throughout the day, regardless of meals.

Patients are reminded here that patients who need to take atorvastatin should use it correctly under the guidance of a doctor.

Atorvastatin has been on the market in China for some time. Has atorvastatin been included in medical insurance?

It is understood that it is a medicine for medical insurance and has been included in the "Basic Medical Insurance Drug Catalog", and patients can use medical insurance for reimbursement.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.

Recommended related articles:

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。